Concepedia

Yingying Dou

YD

Statistics

Publications

4

Citations

112

H-Index

4

Active since

2015

Affiliations

Erasmus MC(Current)

ISA Pharmaceuticals (Netherlands)

Yingying Dou is an author at Erasmus MC specializing in immunology, adaptive immunity, and life sciences.

Publications per year

2015–2020

4

Publications

4

Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage

Carolien E. van de Sandt, Yingying Dou, Stella E. Vogelzang-van Trierum et al. · Journal of General Virology · 2015 · 52 citations · Full text

, , +17

HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo

Yingying Dou, Nadine van Montfoort, Aniek van den Bosch et al. · The Journal of Infectious Diseases · 2017 · 21 citations · Full text

, , +16

Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients

Yingying Dou, Diahann T. S. L. Jansen, Aniek van den Bosch et al. · Antiviral Research · 2020 · 20 citations · Full text

, , +17

Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength

Monique T.A. de Beijer, Diahann T. S. L. Jansen, Yingying Dou et al. · Journal of Virology · 2019 · 19 citations · Full text

, , +17

1–4 of 4